PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,632,000 | +109.3% | 157,464 | -7.7% | 0.00% | – |
| Q3 2020 | $1,735,000 | -28.9% | 170,525 | +4.1% | 0.00% | -100.0% |
| Q2 2020 | $2,440,000 | +29.2% | 163,820 | +5.7% | 0.00% | – |
| Q1 2020 | $1,889,000 | -39.6% | 154,964 | -21.5% | 0.00% | – |
| Q4 2019 | $3,126,000 | +212.0% | 197,530 | +141.9% | 0.00% | – |
| Q3 2019 | $1,002,000 | – | 81,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $140,713,000 | 1.77% |
| Omega Fund Management, LLC | 187,538 | $1,909,000 | 0.52% |
| Boxer Capital, LLC | 1,123,105 | $11,433,000 | 0.40% |
| RA Capital Management | 1,915,568 | $19,500,000 | 0.36% |
| DAFNA Capital Management LLC | 75,000 | $764,000 | 0.25% |
| QVT Financial LP | 133,690 | $1,361,000 | 0.17% |
| Woodline Partners LP | 385,480 | $3,924,000 | 0.13% |
| Virtus ETF Advisers LLC | 19,773 | $201,000 | 0.10% |
| WEXFORD CAPITAL LP | 37,963 | $386,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 53,018 | $540,000 | 0.09% |